SCHEDULE: River Global Investors Adjusts Maxcyte Stake Amid Fund Changes

River Global Investors LLP reports a shift in beneficial ownership of Maxcyte, Inc. equity due to an acquisition of its parent entity, with a portion of voting rights transferring to Liontrust Investment Partners.

Summary

• River Global Investors LLP (RGI LLP) is filing this Schedule 13D to report changes in its beneficial ownership of Maxcyte, Inc. equity.
• The change is a result of an extraordinary corporate transaction involving the acquisition of River Global Holdings Limited.
• As of July 31, 2026, Liontrust Investment Partners (LIP) LLP assumed responsibility for certain River Global Investors funds.
• Approximately 4.3% of the relevant voting rights have transferred from RGI LLP to LIP LLP.
• RGI LLP continues to hold approximately 0.8% of the voting rights, which are slated for future transfer.
• The total number of shares beneficially owned by RGI LLP is 834,100, representing 0.8% of the class.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a neutral to slightly negative filing, primarily due to the transfer of voting rights and the ongoing nature of fund management changes, which introduce a degree of uncertainty.

Positives

• The filing clearly outlines the reasons for the change in beneficial ownership, providing transparency.
• The remaining 0.8% stake held by RGI LLP indicates continued, albeit reduced, involvement.

Negatives

• A significant portion of voting rights (approx. 4.3%) has been transferred away from River Global Investors LLP.
• The ongoing nature of fund management changes and subsequent transfers suggests potential instability or restructuring.
• The reduction in beneficial ownership percentage from an implied previous holding to 0.8% indicates a decreased influence.

Risks

• The transfer of voting rights to a new entity (Liontrust Investment Partners) could lead to changes in investment strategy or shareholder activism.
• Further transfers of remaining voting rights may occur, leading to continued shifts in beneficial ownership.
• The underlying reasons for the acquisition of River Global Holdings Limited and its impact on RGI LLP's operations are not fully detailed, posing a potential unknown risk.

Future Outlook

The filing indicates that the remaining voting rights held by RGI LLP will be transferred at a later stage, suggesting further changes in beneficial ownership are anticipated.

Management Comments

• As per the Announcement on 24 June 2026 (RNS Number: 4421J), the FCA has approved the change in control and proposed acquisition of River Global Holdings Limited.
• Subsequently, as of close of business on 31 July 2026, Liontrust Investment Partners (LIP) LLP assumed responsibility for the River Global Investors (RGI) LLP ICVC and ICAV funds.
• The relevant voting rights (approx 4.3%) attached to those holdings have therefore transferred from RGI LLP to LIP LLP.
• The remaining voting rights (approx 0.8%) continue to be held by RGI LLP and will be transferred at a later stage.

Industry Context

StockSavvy.ai notes that shifts in beneficial ownership, particularly involving investment firms and fund management changes, are common in the asset management industry. This filing reflects a typical restructuring event where voting rights are reallocated due to M&A activity or fund consolidation.

Stakeholder Impact

• Shareholders: Potential shift in influence and voting power due to the transfer of rights to Liontrust Investment Partners.
• River Global Investors LLP: Reduced beneficial ownership and control over Maxcyte, Inc. equity.
• Liontrust Investment Partners LLP: Increased beneficial ownership and voting power in Maxcyte, Inc.

Next Steps

• Transfer of the remaining 0.8% voting rights held by RGI LLP at a later stage.

Key Dates

Keywords

Maxcyte, Schedule 13D, River Global Investors, Liontrust Investment Partners, Change of Control, Beneficial Ownership, Voting Rights, Equity